Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Weynants

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized studyY Humblet, M Symann, A Bosly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanomaP R Dunbar, J L Chen, D Chao, et al.
International Journal of Cancer|December 11, 1995
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3M Marchand, P Weynants, E Rankin, et al.
The Journal of Experimental Medicine|December 22, 1999
A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcriptionB J Van Den Eynde, B Gaugler, M Probst-Kepper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib studyV D'Hondt, P Weynants, Y Humblet, et al.
International Journal of Cancer|October 15, 1989
Presence on a human melanoma of multiple antigens recognized by autologous CTLB Van den Eynde, P Hainaut, M Hérin, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Genes coding for tumor antigens recognized by human cytolytic T lymphocytesP G Coulie, P Weynants, F Lehmann, et al.
Cancer Research|April 28, 2001
High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survivalV Karanikas, D Colau, J F Baurain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesineJ F Vansteenkiste, J E Vandebroek, K L Nackaerts, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II studyU Gatzemeier, F A Shepherd, T Le Chevalier, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized studyY Humblet, M Symann, A Bosly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanomaP R Dunbar, J L Chen, D Chao, et al.
International Journal of Cancer|December 11, 1995
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3M Marchand, P Weynants, E Rankin, et al.
The Journal of Experimental Medicine|December 22, 1999
A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcriptionB J Van Den Eynde, B Gaugler, M Probst-Kepper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib studyV D'Hondt, P Weynants, Y Humblet, et al.
International Journal of Cancer|October 15, 1989
Presence on a human melanoma of multiple antigens recognized by autologous CTLB Van den Eynde, P Hainaut, M Hérin, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Genes coding for tumor antigens recognized by human cytolytic T lymphocytesP G Coulie, P Weynants, F Lehmann, et al.
Cancer Research|April 28, 2001
High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survivalV Karanikas, D Colau, J F Baurain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesineJ F Vansteenkiste, J E Vandebroek, K L Nackaerts, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II studyU Gatzemeier, F A Shepherd, T Le Chevalier, et al.
Pageof 6